Based on the bioinformatics analysis, CEACAM1 was found to have the potential to regulate apoptosis in breast cancer, and overexpression of CEACAM1-3L and 4L in BLBC cells was identified to significantly suppress the proliferative activity of cancer cells by CCK-8 assay (Suppl. Here, CEACAM1 is linked to breast carcinoma.